Tenaya Therapeutics, Inc.
TNYA
$0.73
-$0.01-1.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.34M | 225.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.34M | 225.00K | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.34M | 225.00K | -- | -- | -- |
| SG&A Expenses | 22.40M | 23.71M | 24.72M | 24.71M | 25.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.01M | 86.08M | 93.33M | 97.21M | 102.98M |
| Operating Income | -82.68M | -85.86M | -93.33M | -97.21M | -102.98M |
| Income Before Tax | -103.12M | -83.01M | -90.60M | -94.26M | -99.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -103.12 | -83.01 | -90.60 | -94.26 | -99.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -103.12M | -83.01M | -90.60M | -94.26M | -99.62M |
| EBIT | -82.68M | -85.86M | -93.33M | -97.21M | -102.98M |
| EBITDA | -75.52M | -78.32M | -84.90M | -88.51M | -94.05M |
| EPS Basic | -0.53 | -0.47 | -0.63 | -0.79 | -0.96 |
| Normalized Basic EPS | -0.27 | -0.29 | -0.39 | -0.49 | -0.60 |
| EPS Diluted | -0.53 | -0.47 | -0.63 | -0.79 | -0.96 |
| Normalized Diluted EPS | -0.27 | -0.29 | -0.39 | -0.49 | -0.60 |
| Average Basic Shares Outstanding | 772.85M | 718.07M | 611.05M | 522.41M | 445.23M |
| Average Diluted Shares Outstanding | 772.85M | 718.07M | 611.05M | 522.41M | 445.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |